Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone in acute stroke.

G Mulley, R G Wilcox, J R Mitchell

    British Medical Journal
    |October 7, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Dexamethasone did not improve survival or quality of life for acute stroke patients one year after treatment. This study found no evidence to support routine dexamethasone use in diverse stroke patient groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.

    Journal of internal medicine·2020
    Same author

    Live predator stress in adolescence results in distinct adult behavioral consequences and dorsal diencephalic brain activation patterns.

    Behavioural brain research·2020
    Same author

    Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.

    AJNR. American journal of neuroradiology·2019
    Same author

    Retrospective Validation of a Computer-Assisted Quantification Model of Intracerebral Hemorrhage Volume on Accuracy, Precision, and Acquisition Time, Compared with Standard ABC/2 Manual Volume Calculation.

    AJNR. American journal of neuroradiology·2017
    Same author

    MRI-Based Texture Analysis to Differentiate Sinonasal Squamous Cell Carcinoma from Inverted Papilloma.

    AJNR. American journal of neuroradiology·2017
    Same author

    Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension.

    Diabetes, obesity & metabolism·2015
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Neurology
    • Clinical Medicine
    • Pharmacology

    Background:

    • Acute stroke is a leading cause of death and disability worldwide.
    • Corticosteroids like dexamethasone are sometimes used in inflammatory conditions, but their efficacy in acute stroke is unclear.

    Purpose of the Study:

    • To investigate the effectiveness of dexamethasone in improving outcomes for patients admitted with acute stroke.
    • To assess the impact of dexamethasone on survival rates and quality of life one year post-stroke.

    Main Methods:

    • A randomized controlled trial involving 118 patients admitted with acute stroke.
    • Patients were randomly assigned to receive either dexamethasone or a placebo.
    • Outcomes including survival and quality of life were evaluated at the one-year follow-up mark.

    Related Experiment Videos

    Main Results:

    • No statistically significant difference was observed in the number of survivors between the dexamethasone and placebo groups at one year.
    • Quality of life assessments at one year also showed no significant variation between the two treatment arms.
    • The study found no discernible benefit of dexamethasone administration in this patient cohort.

    Conclusions:

    • Routine administration of dexamethasone is not indicated for a heterogeneous group of acute stroke patients.
    • Further research may be needed to identify specific stroke subgroups that could potentially benefit from dexamethasone therapy.
    • Current evidence does not support the use of dexamethasone as a standard treatment for acute stroke.